Lemaitre Dan 4
4 · GLOBUS MEDICAL INC · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Lemaitre Dan
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-21−13,278→ 1,722 totalExercise: $65.05Exp: 2031-01-14→ Class A Common Stock (13,278 underlying) - Sale
Class A Common Stock
2024-11-21$85.00/sh−13,278$1,128,630→ 0 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-22−1,097→ 625 totalExercise: $65.05Exp: 2031-01-14→ Class A Common Stock (1,097 underlying) - Sale
Class A Common Stock
2024-11-22$85.02/sh−1,097$93,263→ 0 total - Exercise/Conversion
Class A Common Stock
2024-11-21$65.05/sh+13,278$863,734→ 13,278 total - Exercise/Conversion
Class A Common Stock
2024-11-22$65.05/sh+1,097$71,360→ 1,097 total
Footnotes (2)
- [F1]These options were granted on January 14, 2021 and are fully vested.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.